AT
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
nancy Chang
Former Chairman and Senior Managing Director, Caduceus Asia Partners at OrbiMed Advisors·OrbiMed
Bio
Professional summary
Nancy Chang is a biopharmaceutical entrepreneur and investor who previously led OrbiMed's Asia fund as founder, chairperson and senior managing director of Caduceus Asia Partners from 2007 to 2012. Before OrbiMed, she co-founded Tanox and served as its president, CEO and chair until its acquisition by Genentech. She has also served on boards including Ansun Biopharma, Charles River Laboratories, BioHouston and the Federal Reserve Bank in Houston.
Background
Career, education, and skills
Career history
- Apex CapitalChairman and Founder2009 – Present
- Tang Family FoundationPresident2009 – Present
- OrbiMed AdvisorsFounder, Chairperson and Senior Managing Director, Caduceus Asia Partners2007 – 2012
- TanoxCo-Founder, President, CEO and Chairman1986 – 2006
- Baylor College of MedicineAssociate Professor of Virology1986 – 1991
- CentocorDirector of Research
Education
- Harvard UniversityDoctorate in Biological Chemistry
Other partners at OrbiMed
12 more profiles
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
BC
Brendan Weber, CFA
Principal
OrbiMed
Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.
CG
Carl Gordon
Managing Partner
OrbiMed
OrbiMed Managing Partner leading private equity and biotech company formation.
Carl L. Gordon
Managing Partner
OrbiMed
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.
CN
Carter Neild
Managing Partner
OrbiMed
OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.
Clay Daniel DeMarcus
Principal
OrbiMed
Principal focused on medical technology and non-therapeutics venture investing.
CS
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.